CStone Pharmaceuticals (CStone Pharmaceuticals) Equity-to-Asset : 0.00 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is CStone Pharmaceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CStone Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $0.00 Mil. CStone Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2023 was $0.00 Mil.

The historical rank and industry rank for CStone Pharmaceuticals's Equity-to-Asset or its related term are showing as below:

CSPHF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27 Med: 0.64 Max: 0.86
Current: 0.28

During the past 8 years, the highest Equity to Asset Ratio of CStone Pharmaceuticals was 0.86. The lowest was 0.27. And the median was 0.64.

CSPHF's Equity-to-Asset is ranked worse than
76.26% of 1567 companies
in the Biotechnology industry
Industry Median: 0.66 vs CSPHF: 0.28

CStone Pharmaceuticals Equity-to-Asset Historical Data

The historical data trend for CStone Pharmaceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Equity-to-Asset Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.84

0.79

0.53

0.27

0.28

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial									0.53	0.47	0.27	-	0.28

Competitive Comparison of CStone Pharmaceuticals's Equity-to-Asset

For the Biotechnology subindustry, CStone Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CStone Pharmaceuticals's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's Equity-to-Asset falls into.

CStone Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

CStone Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	63.98	/	232.766
	=	0.27

CStone Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	0	/	0
	=

CStone Pharmaceuticals (OTCPK:CSPHF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

CStone Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (CStone Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (OTCPK:CSPHF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.